CHINET 2007 surveillance of bacterial resistance in China

Chinese Journal of Infection and Chemotherapy

Volumn 8, Issue 5, 2008, Pages 325-333

  Wang, Fu ^a   Zhu, De Mei ^a   Hu, Fu Pin ^a   Ruan, Fei Yi ^a   Ni, Yu Xing ^a   Sun, Jing Yong ^a   Xu, Ying Chun ^a   Sun, Hong Li ^a   Hu, Yun Jian ^a   Ai, Xiao Man ^a   Yu, Yun Song ^a   Yang, Qing ^a   Sun, Zi Yong ^a   Jian, Cui ^a   Jia, Bei ^a   Huang, Wen Xiang ^a   Zhuo, Chao ^a   Su, Dan Hong ^a   Wei, Lian Hua ^a   Wu, Ling ^a   Zhang, Chao Xia ^a   Ji, Ping ^a   Wang, Chuan Qing ^a   Xue, Jian Chang ^a   Zhang, Hong ^a   Li, Wan Hua ^a   more..

^a FUDAN UNIVERSITY   (China)

Author keywords

Bacterial resistance; Bacterial susceptibility testing; Multi drug resistant strain; Pan resistant strain

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFOTAXIME; CEFPROZIL; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; EXTENDED SPECTRUM BETA LACTAMASE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METICILLIN; MINOCYCLINE; NITROFURANTOIN; OXACILLIN; PENICILLIN G; RIFAMPICIN; SULPERAZON; SULTAMICILLIN; TEICOPLANIN; UNINDEXED DRUG; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; BURKHOLDERIA; CHINA; CLINICAL EFFECTIVENESS; ENTEROBACTERIACEAE; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENZYME SYNTHESIS; ESCHERICHIA COLI; GENERAL HOSPITAL; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; INFECTION CONTROL; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NONHUMAN; PEDIATRIC HOSPITAL; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; VANCOMYCIN RESISTANT ENTEROCOCCUS;

EID: 53349108003     PISSN: 10097708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Chinese source.
2. Clinical and Laboratory Standards Institute(CLSI). Performance Standards for Antimicrobial susceptibility testing[S]. 2007.
3. Rodriguez-Bano J, Paterson DL. A change in the epidemicology of infections due to exterded-spectrum β-lactamase-producing organisms[J]. Clin Infect Dis, 2006,42(7):935-937.
4. Paterson DL. The epidemiological profile of infections with multidrug resistant Preudomonas aeruginosa and Acinetobacter species[J]. Clin Infect Dis,2006, 43(suppl 2):S43-S48.
5. Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa[J]. Clin Infect Dis, 2006, 43(suppl 2):S49-S56.
6. Chinese source.
7. Zavascki AP, Goldani LZ, Li J, et al. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review [J]. J Anitmicrob Chemother, 2007, 60(6):1206-1215.
8. Li J, Nation RL, Turnidge JD, et al. Colistin:the re-emerging antibiotic for multidrug-resistant Gram-regative bacterial infections[J]. Lancet Infect Dis,2006, 6(9):589-601.
9. Rahal JJ. Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species[J]. Clin Infect Dis,2006, 43(suppl 2):S95-S99.